We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Fresenius Medical Care AG | NYSE:FMS | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.69 | -3.19% | 20.97 | 21.57 | 20.965 | 21.46 | 494,745 | 22:58:41 |
From May 2019 to May 2024
By Max Bernhard
Fresenius Medical Care AG & Co. KGaA (FME.XE), or FMC, and its largest shareholder Fresenius SE & Co. KGaA (FRE.XE) both expect U.S. tax reform to have a positive impact on 2017 after-tax earnings, the companies said late Friday.
FMC expects positive effects of around EUR200 million ($237.3 million) on after-tax earnings, while Fresenius said it expects a one-off gain of around EUR90 million in 2017 group net income. Of the total, EUR60 million will stem from its holding in FMC, while EUR30 million would be from Fresenius Kabi, Fresenius said.
The new U.S. tax legislation will come into effect on January 1 and triggers the revaluation of deferred tax liabilities.
Write to Max Bernhard at Max.Bernhard@dowjones.com; @mxbernhard
(END) Dow Jones Newswires
December 27, 2017 02:01 ET (07:01 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year Fresenius Medical Care Chart |
1 Month Fresenius Medical Care Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
